BlackRock
GTBP icon

BlackRock’s GT Biopharma GTBP Stock Holding History

BlackRock’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.07K Sell
8,312
-96
-1% -$39 ﹤0.01% 5505
2026
Q1 		$3.43K Sell
8,408
-1
-0% -$1 ﹤0.01% 5484
2025
Q4 		$6.6K Sell
8,409
-1,328
-14% -$943 ﹤0.01% 5321
2025
Q3 		$5.71K Hold
9,737
– – ﹤0.01% 5258
2025
Q2 		$34.9K Hold
9,737
– – ﹤0.01% 5057
2025
Q1 		$20.9K Hold
9,737
– – ﹤0.01% 5083
2024
Q4 		$29.7K Hold
9,737
– – ﹤0.01% 5046
2024
Q3 		$22.5K Sell
9,737
-31
-0.3% -$74 ﹤0.01% 4924
2024
Q2 		$27.6K Sell
9,768
-364
-4% -$1.3K ﹤0.01% 4959
2024
Q1 		$44.9K Sell
10,132
-3
-0% -$16 ﹤0.01% 4894
2023
Q4 		$77.5K Hold
10,135
– – ﹤0.01% 4875
2023
Q3 		$73.3K Sell
10,135
-25
-0.2% -$207 ﹤0.01% 4922
2023
Q2 		$95.1K Sell
10,160
-2,342
-19% -$24.3K ﹤0.01% 4932
2023
Q1 		$206K Buy
12,502
+76
+0.6% +$1.74K ﹤0.01% 4760
2022
Q4 		$330K Buy
12,426
+33
+0.3% +$1.65K ﹤0.01% 4716
2022
Q3 		$654K Sell
12,393
-159
-1% -$12.2K ﹤0.01% 4637
2022
Q2 		$1.13M Sell
12,552
-25,822
-67% -$1.96M ﹤0.01% 4491
2022
Q1 		$3.31M Sell
38,374
-494
-1% -$43.6K ﹤0.01% 4172
2021
Q4 		$3.56M Buy
38,868
+360
+0.9% +$53.9K ﹤0.01% 4143
2021
Q3 		$7.79M Sell
38,508
-8,605
-18% -$2.59M ﹤0.01% 3790
2021
Q2 		$21.9M Buy
+47,113
New +$19.6M ﹤0.01% 3241

Other funds holding GTBP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
KP
Kitching Partners Conshohocken, Pennsylvania $116M AUM 16.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return

BlackRock's GTBP Position: Q2 2026 in Review

BlackRock reduced its GT Biopharma (GTBP) stake by 1.1% in Q2 2026, selling an estimated $39 and leaving 8,312 shares worth $4.07K. The position accounts for ﹤0.01% of the portfolio, ranked #5505.

BlackRock first reported a position in GTBP in Q2 2021 and has held it in 21 quarters since. The position peaked at $21.9M in Q2 2021. 41 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • BlackRock held 8,312 shares of GT Biopharma worth $4.07K as of Q2 2026.
  • BlackRock sold 96 GT Biopharma shares in Q2 2026, an estimated $39.
  • GT Biopharma made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5505 holding.
  • BlackRock first reported a position in GT Biopharma in Q2 2021 and has held it in 21 quarters since.
  • BlackRock's GT Biopharma position peaked at $21.9M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.